states drive cancer progression and therapeutic response (Nat Biotech, 2026), with a particular emphasis on rare and refractory cancers multidisciplinary, spanning clinical, translational, and basic science. The lab leverages resources from the TRACER program, including
Salary:$80.17k - $91.3k
- ID: #55028735
- State: Washington Seattle-tacoma 98101 Seattle-tacoma USA
- City: Seattle-tacoma
- Salary: $80.17k - $91.3k
- Showed: 2026-05-02
- Deadline: 2026-06-30
- Category: Science/biotech